维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Mozzetti"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Semiquantitative RTPCR analysis to assess the expression levels of multiple tran- scripts from the same samples显示文摘	Marone M Mozzetti S Ritis D D	2001	Biol Proeed2001，3，：	1
2	High cycling-dependent kinase inhibitors in Bcl-2 and Bcl-xl-expressing CD34^+-proliferating haematopoietic progenitors显示文摘	Marone M Pierelli L Mozzetti S	2000	Br J Haematol2000，110，3：	1
3	Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance显示文摘	Ferlini C Raspaglio G Mozzetti S	2003	Mol Pharmacol2003，64，1：	1
4	Class I11 beta-tubulin overex- pression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
5	Bcl-2,bax,bcl-XL and bcl-XS expression innormal and neoplastic ovarian tissues显示文摘	Marone M Scambia G Mozzetti S	1998	Clinical CancerRes1998，，4：	1
6	Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample显示文摘	Marone M Mozzetti S DeRitis D	2001	Biol Proced Online2001，3，1：	1
7	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
8	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
9	Class Ⅲβ-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
10	Variation in enzyme activities in leaves and cell suspensions as markers of incompatibility in different phytophthora-pepper interactions显示文摘	Mozzetti C Ferraris L Tamietti G	1995	Physiol Mol Plant Pathol1995，46，：	1
11	High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-exoressing CD34 +-proliferating haematopoietic progenitors显示文摘	Marone M Pierelli L Mozzetti S	2000	British Journal of Haematology2000，110，3：	1
12	Class Ⅲ beta-tubulin over expression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	MOZZETTI S FERLINI C CONCOLINO P	2005	Clin Cancer Res2005，11，1：	1
13	Class Ⅲ betatubulin overexpression is a prominent mechanism of paditaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
14	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
15	Chemoresistanttumor cell lines display altered epidermal growth factor re-ceptor and HER3 signaling and enhanced sensitivity to ge-fitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
16	Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample显示文摘	Marone M Mozzetti S de Ritis D	2001	Biol Proced2001，3，1：	1
17	Chemoresistant tumor cell lines display ahered epidennal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib显示文摘	Servidei T Riccardi A Mozzetti S	2008	Int J Cancer2008，123，12：	1
18	Molecular mechanisms of patupilone resistance显示文摘	Mozzetti S Iantomasi R De Maria I	2008	Cancer Res2008，68，10：	1
19	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
20	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示